ViroPharma to Present at the Banc of America Securities 2005 Specialty Pharmaceuticals Conference
25 juil. 2005 10h49 HE
|
ViroPharma Incorporated
EXTON, Pa., July 25, 2005 (PRIMEZONE) -- ViroPharma Incorporated (Nasdaq:VPHM) today announced that it will present at the Banc Of America Securities 2005 Specialty Pharmaceuticals Conference, at...
ViroPharma Announces Elimination of 2009 Debt
05 juil. 2005 16h47 HE
|
ViroPharma Incorporated
EXTON, Pa., July 5, 2005 (PRIMEZONE) -- ViroPharma Incorporated (Nasdaq:VPHM) today announced that it has delivered notice that it will exercise its right to automatically convert the remaining...
ViroPharma Announces Execution on Extensive Debt Reduction Effort
20 juin 2005 08h45 HE
|
ViroPharma Incorporated
EXTON, Pa., June 20, 2005 (PRIMEZONE) -- ViroPharma Incorporated (Nasdaq:VPHM) today announced that it will exercise its right to automatically convert $18.75 million principal amount of its 6%...
ViroPharma To Present at the Friedman Billings Ramsey 9th Annual Growth Investor Conference
27 mai 2005 11h45 HE
|
ViroPharma Incorporated
EXTON, Pa., May 27, 2005 (PRIMEZONE) -- ViroPharma Incorporated (Nasdaq:VPHM) today announced that it will present at the Friedman Billings Ramsey 9th Annual Growth Investor Conference, at 8:20 a.m....
ViroPharma Announces Advancement of HCV-796 Into Phase 1B Clinical Testing In Hepatitis C Patients
24 mai 2005 09h40 HE
|
ViroPharma Incorporated
EXTON, Pa., May 24, 2005 (PRIMEZONE) -- ViroPharma Incorporated (Nasdaq:VPHM) today announced the commencement of a Phase 1b proof of concept clinical study in hepatitis C positive patients with...
ViroPharma to Present at the Fourth Annual Needham Biotechnology Conference
19 mai 2005 13h45 HE
|
ViroPharma Incorporated
EXTON, Pa., May 19, 2005 (PRIMEZONE) -- ViroPharma Incorporated (Nasdaq:VPHM) today announced that it will present at the Fourth Annual Needham Biotechnology Conference, at 3:30 P.M. Eastern Time on...
ViroPharma to Present at the Imperial Capital 2005 Equity Conference
17 mai 2005 12h30 HE
|
ViroPharma Incorporated
EXTON, Pa., May 17, 2005 (PRIMEZONE) -- ViroPharma Incorporated (Nasdaq:VPHM) today announced that it will present at Imperial Capital 2005 Special Situations Equity Conference, at 2:45 P.M. Eastern...
ViroPharma To Present at the 2005 Bank Of America Securities Health Care Conference
13 mai 2005 11h01 HE
|
ViroPharma Incorporated
EXTON, Pa., May 13, 2005 (PRIMEZONE) -- ViroPharma Incorporated (Nasdaq:VPHM) today announced that it will present at the Bank of America Securities Health Care Conference, at 6:20 p.m. Eastern Time...
ViroPharma Announces Debt Reduction Of $29 Million
11 mai 2005 08h30 HE
|
ViroPharma Incorporated
EXTON, Pa., May 11, 2005 (PRIMEZONE) -- ViroPharma Incorporated (Nasdaq:VPHM) today announced the purchase of $29.0 million of its outstanding 6% convertible subordinated notes due March 2007....
ViroPharma Incorporated Reports First Quarter 2005 Financial Results and Increases 2005 Vancocin Pulvules Net Sales Guidance
03 mai 2005 14h20 HE
|
ViroPharma Incorporated
EXTON, Pa., May 3, 2005 (PRIMEZONE) -- ViroPharma Incorporated (Nasdaq:VPHM) reported today its financial results for the first quarter ended March 31, 2005.
Quarter ended March 31, 2005
For the...